LCN2 and neoplasm: Compared with responders who achieved a partial response after the administration of anti‐PD‐1 immunotherapy, nonresponders who demonstrated an enlargement of tumor size had higher PGAM1 and LCN2 expression as well as lower CD8 expression (Figure 6L).